Matricelf Ltd
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 20… Read more
Matricelf Ltd (MTLF) - Total Assets
Latest total assets as of June 2025: ILA10.99K ILA
Based on the latest financial reports, Matricelf Ltd (MTLF) holds total assets worth ILA10.99K ILA as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Matricelf Ltd - Total Assets Trend (2019–2024)
This chart illustrates how Matricelf Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Matricelf Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Matricelf Ltd's total assets of ILA10.99K consist of 68.9% current assets and 31.1% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0.5% |
| Accounts Receivable | ILA443.00K | 2.4% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA2.61 Million | 14.2% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Matricelf Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Matricelf Ltd's current assets represent 68.9% of total assets in 2024, an increase from 41.9% in 2019.
- Cash Position: Cash and equivalents constituted 0.5% of total assets in 2024, down from 39.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, a decrease from 57.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 14.2% of total assets.
Matricelf Ltd Competitors by Total Assets
Key competitors of Matricelf Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Matricelf Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Matricelf Ltd generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Matricelf Ltd is currently not profitable relative to its asset base.
Matricelf Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.69 | 8.56 | 12.32 |
| Quick Ratio | 2.69 | 8.56 | 12.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA3.62K | ILA 16.48 Million | ILA 23.84 Million |
Matricelf Ltd - Advanced Valuation Insights
This section examines the relationship between Matricelf Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -39.2% |
| Total Assets | ILA18.35 Million |
| Market Capitalization | $388.41K USD |
Valuation Analysis
Below Book Valuation: The market values Matricelf Ltd's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Matricelf Ltd's assets decreased by 39.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Matricelf Ltd (2019–2024)
The table below shows the annual total assets of Matricelf Ltd from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA18.35 Million | -39.24% |
| 2023-12-31 | ILA30.20 Million | -23.52% |
| 2022-12-31 | ILA39.49 Million | +36.64% |
| 2021-12-31 | ILA28.90 Million | +387.01% |
| 2020-12-31 | ILA5.93 Million | +40.83% |
| 2019-12-31 | ILA4.21 Million | -- |